View source for Conditioning regimens for HSCT

{| class="wikitable"
! Regimen
! Drugs
! Comments
|-
! colspan=3 | Myeloablative regimens
|-
| BEAM
| [[Carmustine]], [[etoposide]], [[cytosine arabinoside]], and [[melphalan]]
| Commonly used for non-Hodgkin and Hodgkin lymphoma
|-
| Cy/TBI
| [[Cyclophosphamide]] and TBI
|
|-
| Bu4/Cy
| [[Busulfan]] and [[cyclophosphamide]]
|
|-
| Flu/Bu4
| [[Busulfan]] and [[fludarabine]] for four days
|
|-
| High-dose [[melphalan]]
| [[Melphalan]]
| Used in preparation for autoHSCT in myeloma
|-
| CBV
| [[Carmustine]] once followed by [[etoposide]] and [[cyclophosphamide]] for four days
|
|-
! colspan=3 | Reduced-intensity regimens
|-
| Flu/Mel
| [[Fludarabine]] and [[melphalan]]
|
|-
| Flu/Bu2 and Flu/Bu3
| [[Fludarabine]] and [[busulfan]]
|
|-
| Flu/Cy
| [[Fludarabine]] and [[cyclophosphamide]]
|
|-
| Flu/Bu3/TT
| [[Fludarabine]], [[busulfan]], and [[thiotepa]]
|
|-
! colspan=3 | Non-myeloablative regimens
|-
| Flu/TBI
| [[Fludarabine]] and TBI
|
|-
| TLI/ATG
| Total lymphoid irradiation and [[anti-thymocyte globulin]]
| 
|-
| Low dose TBI
| TBI
|
|}

TBI = total body irradiation

[[Category:Immunocompromised hosts]]